Valuation: EBOS Group Limited

Market Cap 3.54B 2.48B 2.21B 2.03B 1.85B 3.47B 235B 24.28B 9.79B 124B 9.31B 9.11B 392B P/E 2027 *
15.2x
P/E 2028 * 13.2x
Enterprise Value 4.55B 3.19B 2.85B 2.62B 2.38B 4.46B 302B 31.24B 12.59B 160B 11.98B 11.73B 504B EV / Sales 2027 *
0.32x
EV / Sales 2028 * 0.31x
Free-Float
90.8%
Yield 2027 *
5.47%
Yield 2028 * 6.03%
1 day-1.39%
1 week-1.39%
1 month-2.66%
3 months-12.77%
6 months-14.16%
Current year-35.26%
1 week 22.68
Extreme 22.68
22.68
1 month 19.66
Extreme 19.66
23
Current year 19.66
Extreme 19.66
46.64
1 year 19.66
Extreme 19.66
46.64
3 years 19.66
Extreme 19.66
47.23
5 years 19.66
Extreme 19.66
47.23
10 years 19.66
Extreme 19.66
47.23
Manager TitleAgeSince
Chief Executive Officer 51 01/07/2025
Director of Finance/CFO - 30/09/2024
Chief Tech/Sci/R&D Officer - 05/08/2024
Director TitleAgeSince
Chairman 66 -
Director/Board Member - 01/07/2019
Director/Board Member 60 01/07/2021
Change 5-day change 1-year change 3-year change Capi.($)
-1.39%-1.39% - - 2.39B
-0.46%+10.31%+63.52%+143.15% 1,263B
-0.97%+1.60%+43.25%+80.09% 658B
-2.05%+0.73%+32.47%+101.62% 521B
-1.54%+0.18%+53.42%+66.79% 391B
-0.78%+5.51%+72.55%+44.25% 369B
-1.69%+3.17%+32.49%+55.35% 307B
-0.72%+7.83%+11.15%+33.76% 290B
-0.12%+4.68%+55.97%+74.59% 252B
-0.21%+7.34%+42.19%+109.69% 212B
Average -0.93%+5.08%+45.22%+78.81% 473.55B
Weighted average by Cap. -0.74%+5.66%+49.15%+93.29%

Financials

2027 *2028 *
Net sales 14.02B 9.84B 8.78B 8.06B 7.33B 13.74B 931B 96.26B 38.8B 492B 36.92B 36.13B 1,553B 14.64B 10.27B 9.17B 8.42B 7.66B 14.35B 973B 101B 40.52B 513B 38.55B 37.73B 1,621B
Net income 228M 160M 143M 131M 119M 223M 15.12B 1.56B 630M 7.98B 599M 587M 25.21B 263M 185M 165M 151M 138M 258M 17.49B 1.81B 729M 9.23B 693M 679M 29.16B
Net Debt 1.01B 712M 635M 583M 530M 994M 67.38B 6.96B 2.81B 35.56B 2.67B 2.61B 112B 976M 685M 611M 561M 510M 957M 64.82B 6.7B 2.7B 34.21B 2.57B 2.51B 108B
Projected Income Statement - Annual - EBOS Group Limited
Logo EBOS Group Limited
EBOS Group Limited is a marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products. The Company is also the owner, product marketer and distributor of animal care brands. Its segments include Healthcare, Animal Care, and Corporate. The Healthcare segment includes sales of healthcare products in a range of sectors, through its own brands, retail healthcare, pharmacy, hospital and logistic services, and wholesale activities. The Animal Care segment includes sales of animal care products in a range of sectors, own manufactured and contract manufactured brands, retail, and wholesale activities. Its Community Pharmacy business includes Symbion, ProPharma, Pharmacy Wholesalers Russells, TerryWhite Chemmart, Good Price Pharmacy Warehouse, healthSAVE, Ventura Health, Minfos, DoseAid, Intellipharm, Endeavour Consumer Health, and Red Seal. Its contract logistics include Healthcare Logistics, Healthcare Logistics Clinical Trials and Clinect.
Employees
5,364
Date Price Change Volume
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - EBOS Group Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
17.08AUD
Average target price
23.19AUD
Spread / Average Target
+35.76%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - EBOS Group Limited